We are live on ! Find out more
CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$54.5M
BlackRock
2
BlackRock
New York
$49.2M +$4.78M +384,543 +9%
RG
3
Redmile Group
California
$33.2M +$445K +35,800 +1%
EAM
4
Eagle Asset Management
Florida
$31.5M +$9.71M +781,700 +38%
Vanguard Group
5
Vanguard Group
Pennsylvania
$30.9M +$1.37M +109,989 +4%
PA
6
Perceptive Advisors
New York
$30.4M
BC
7
Boxer Capital
California
$23.2M
CTA
8
Carillon Tower Advisers
Florida
$22.8M +$7.63M +614,502 +42%
FCMI
9
Foresite Capital Management IV
California
$22.4M
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$21.9M -$6.21M -500,000 -20%
Franklin Resources
11
Franklin Resources
California
$19.2M -$802K -64,600 -4%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$18.7M -$9M -724,412 -30%
FCMI
13
Foresite Capital Management III
California
$17.3M
DM
14
Deerfield Management
New York
$14.9M
State Street
15
State Street
Massachusetts
$14.6M -$78.7K -6,333 -0.5%
VOYA Investment Management
16
VOYA Investment Management
Georgia
$13M +$2.87M +230,710 +24%
VVM
17
Versant Venture Management
California
$12M +$448K +36,095 +3%
CS
18
Candriam SCA
Luxembourg
$10.6M +$6.06M +488,000 +104%
Citadel Advisors
19
Citadel Advisors
Florida
$10.6M -$11.9M -957,559 -50%
Millennium Management
20
Millennium Management
New York
$10.1M -$3.22M -258,857 -22%
Westfield Capital Management
21
Westfield Capital Management
Massachusetts
$10.1M -$72.5K -5,840 -0.6%
NC
22
Nexthera Capital
New York
$10.1M +$994K +80,009 +10%
VC
23
Vivo Capital
California
$10M
AG
24
Artal Group
Luxembourg
$8.86M
Invesco
25
Invesco
Georgia
$8.12M +$4.73M +380,481 +108%